In 2024, the FDA placed ipamorelin on its list of bulk drug substances that may not be used in compounding, significantly restricting its US availability
Biased: biased effect on GLP-1 receptor on intracellular signalling
Based on prior experience, regardless of analyte, manufacturer, or species, we assume the sensitivity of kits will change between lot numbers
Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP
See the GLP-1 protein shake guide for specific product recommendations
It adds fasting insulin with HOMA-IR to gauge the degree of insulin resistance, liver function tests as a baseline for both drugs, and a lipid panel for cardiovascular risk